by Joel Rothman | Sep 9, 2009 | NutriSupLaw
We are not sure of the reason, but it seems that every three months or so, a national media outlet weighs in on an old story: tainted nutritional supplements. To be sure, the story will not go away in the sports world. Athletes who test positive for steroids often say...
by Joel Rothman | Sep 30, 2006 | NutriSupLaw
Nutraceutical Corp. has filed a motion for rehearing and for rehearing en banc of the decision of the United States Court of Appeals for the Tenth Circuit in Neutraceutical Corp. v. Von Eschenbach, No. 05-4151 (Aug. 17, 2006). The Tenth Circuit’s decision...
by Joel Rothman | Aug 29, 2006 | NutriSupLaw
In a 23 page opinion, a panel of the United States Court of Appeals for the Tenth Circuit has reversed the Utah District Court and held that the FDA’s ban on low dose ephedra was not arbitrary or capricious. Next stop, Supreme Court? Neutraceutical Corp. v. Von...
by Joel Rothman | Jun 18, 2006 | NutriSupLaw
The wisdom of the FDA ban on ephedra has again been called into question, this time by a double-blind placebo controlled study published in the International Journal of Obesity. The study is entitled “Multinutrient supplement containing ephedra and caffeine...
by Joel Rothman | Jun 4, 2006 | NutriSupLaw
MII Liquidation Inc., as the former Metabolife International Inc. is now known, said in a court document filed Wednesday that it had reached agreements to settle the first 21 of hundreds of injury and death lawsuits over its once best-selling ephedra-based dietary...
